Evidence map›Paper›PMID 31441691›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2019

Absence of gravin-mediated signaling inhibits development of high-fat diet-induced hyperlipidemia and atherosclerosis.

Qiying Fan, Xing Yin, Abeer Rababa'h, Andrea Diaz Diaz, Cori S Wijaya, Sonal Singh, Santosh V Suryavanshi, Henry Hiep Vo, Moawiz Saeed, Yang Zhang and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Development of stem cell therapy for atherosclerosis.Molecular and cellular biochemistry · 2024
    Review
  3. Article
  4. Exosomes: Multifaceted Messengers in Atherosclerosis.Current atherosclerosis reports · 2020
    Review
  5. Review
  6. Article
  7. Gravin gravitates atherogenesis to atheroprogression in the obesogenic setting.American journal of physiology. Heart and circulatory physiology · 2019
    Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Qiying FanDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas.
Xing YinDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas.
Abeer Rababa'hDepartment of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
Andrea Diaz DiazDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas.
Cori S WijayaDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas.
Sonal SinghDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas.
Santosh V SuryavanshiDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas.
Henry Hiep VoDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas.
Moawiz SaeedDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas.
Yang ZhangDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas.
Bradley K McConnellDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas.ORCID 0000-0001-8712-0336
University of Houston · USJordan University of Science and Technology · JO

Funding

Targeted Disruption of Beta-Adrenergic Signaling to Increase Cardiac ContractilitR01HL085487 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI MCCONNELL, BRADLEY K · 2007 to 2011
$2.3M
Endothelial Inflammasomes in Coronary Microcirculation -Beyond InflammationR01HL122769 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI ZHANG, YANG · 2014 to 2018
$1.9M
Gravin Signalosome Protein Coordinates Cardiac Function via Adrenergic Receptor SignalingR15HL141963 · NHLBI · UNIVERSITY OF HOUSTON · PI MCCONNELL, BRADLEY K · 2019 to 2019
$459k
Scaffolding Protein Interaction Network Regulates Cardiac Cell SignalingR15HL124458 · NHLBI · UNIVERSITY OF HOUSTON · PI MCCONNELL, BRADLEY K · 2015 to 2015
$452k
NHLBI NIH HHS R01 HL085487NHLBI NIH HHS R01 HL122769NHLBI NIH HHS R15 HL124458NHLBI NIH HHS R15 HL141963
6 · The paper itself

Abstract

Gravin, an A-kinase anchoring protein, is known to play a role in regulating key processes that lead to inflammation and atherosclerosis development, namely, cell migration, proliferation, and apoptosis. We investigated the role of gravin in the development of high-fat diet (HFD)-induced atherosclerosis and hyperlipidemia. Five-week-old male wild-type (WT) and gravin-t/t mice were fed a normal diet or an HFD for 16 wk. Gravin-t/t mice showed significantly lower liver-to-body-weight ratio, cholesterol, triglyceride, and very low-density lipoprotein levels in serum as compared with WT mice on HFD. Furthermore, there was less aortic plaque formation coupled with decreased lipid accumulation and liver damage, as the gravin-t/t mice had lower levels of serum alanine aminotransferase and aspartate aminotransferase. Additionally, gravin-t/t HFD-fed mice had decreased expression of liver 3-hydroxy-3-methyl-glutaryl-CoA reductase, an essential enzyme for cholesterol synthesis and lower fatty acid synthase expression. Gravin-t/t HFD-fed mice also exhibited inhibition of sterol regulatory element binding protein-2 (SREBP-2) expression, a liver transcription factor associated with the regulation of lipid transportation. In response to platelet-derived growth factor receptor treatment, gravin-t/t vascular smooth muscle cells exhibited lower intracellular calcium transients and decreased protein kinase A- and protein kinase C-dependent substrate phosphorylation, notably involving the Erk1/2 signaling pathway. Collectively, these results suggest the involvement of gravin-dependent regulation of lipid metabolism via the reduction of SREBP-2 expression. The absence of gravin-mediated signaling lowers blood pressure, reduces plaque formation in the aorta, and decreases lipid accumulation and damage in the liver of HFD mice. Through these processes, the absence of gravin-mediated signaling complex delays the HFD-induced hyperlipidemia and atherosclerosis.

Indexed as

Diet, High-FatPlaque, AtheroscleroticA Kinase Anchor ProteinsAnimalsAortaAortic DiseasesAtherosclerosisCell Cycle ProteinsCyclic AMP-Dependent Protein KinasesDisease Models, AnimalExtracellular Signal-Regulated MAP KinasesHydroxymethylglutaryl CoA ReductasesHyperlipidemiasLipidsLiverMaleAkap12 protein, mouseA Kinase Anchor ProteinsCell Cycle ProteinsCyclic AMP-Dependent Protein KinasesExtracellular Signal-Regulated MAP KinasesHmgcr protein, mouseHydroxymethylglutaryl CoA ReductasesLipidsProtein Kinase CSrebf2 protein, mouseSterol Regulatory Element Binding Protein 2A-kinase anchoring protein 12atherosclerosisgravinhigh-fat diethyperlipidemialipoproteins

Identifiers

PMID31441691
PMCPMC6843010
OpenAlexW2969468596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.